Advertisement
Advertisement
COR
Cencora, Inc.
352.73
USDSponsored
+2.43
+0.69%
Mar 12, 16:00 UTC -4
Closed
After-Market
352.69
-0.05
-0.01%
COR Earnings Reports
Positive Surprise Ratio
COR beat 37 of 40 last estimates.
93%
Next Report
Date of Next Report
May 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$82.41B
/$4.93
Implied change from Q1 26 (Revenue/ EPS)
-4.10%
/+20.83%
Implied change from Q2 25 (Revenue/ EPS)
+9.22%
/+11.54%
Cencora, Inc. earnings per share and revenue
On Feb 04, 2026, COR reported earnings of 4.08 USD per share (EPS) for Q1 26, beating the estimate of 4.07 USD, resulting in a 0.03% surprise. Revenue reached 85.93 billion, compared to an expected 86.89 billion, with a -1.10% difference. The market reacted with a -8.79% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 17 analysts forecast an EPS of 4.93 USD, with revenue projected to reach 82.41 billion USD, implying an increase of 20.83% EPS, and decrease of -4.10% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Ardent Health, Inc.
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.34
Actual
$0.32
Surprise
-8.23%
Nutex Health Inc. Common Stock
Report Date
Mar 05, 2026 For Q4 25
Estimate
$6.97
Actual
$1.61
Surprise
-76.92%
Omada Health, Inc. Common Stock
Report Date
Mar 05, 2026 For Q4 25
Estimate
-$0.05
Actual
$0.08
Surprise
+252.96%
Sonida Senior Living, Inc.
Report Date
Mar 11, 2026 For Q4 25
Estimate
-$1.25
Actual
-$1.29
Surprise
-2.41%
Enhabit, Inc.
Report Date
Mar 04, 2026 For Q4 25
Estimate
$0.14
Actual
$0.14
Surprise
-3.11%
CryoPort, Inc. Common Stock
Report Date
Mar 03, 2026 For Q4 25
Estimate
-$0.20
Actual
-$0.27
Surprise
-28.76%
Auna S.A.
Report Date
Mar 10, 2026 For Q4 25
Estimate
-Actual
$1.81
Surprise
-
Shoulder Innovations, Inc.
Report Date
Mar 10, 2026 For Q4 25
Estimate
-$0.33
Actual
-$0.38
Surprise
-14.49%
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
FAQ
What were Cencora, Inc.'s earnings and revenue for the latest quarter Q1 2026?
For Q1 2026, Cencora, Inc. reported EPS of $4.08, missing estimates by 0.03%, and revenue of $85.93B, -1.1% below expectations.
How did the market react to Cencora, Inc.'s Q1 2026 earnings?
The stock price moved down -8.79%, changed from $361.75 before the earnings release to $329.97 the day after.
When is Cencora, Inc. expected to report next?
The next earning report is scheduled for May 05, 2026.
What are the forecasts for Cencora, Inc.'s next earnings report?
Based on 17
analysts, Cencora, Inc. is expected to report EPS of $4.93 and revenue of $82.41B for Q2 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement